ATOSSA THERAPEUTICS, INC. — Director's Dealing 2016

May 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ATOSSA GENETICS INC (ATOS)
CIK: 0001488039
Period of Report: 2016-05-18

Reporting Person: Remmel H. Lawrence (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-18	Stock Option (right to buy)	$0.263	A	132634	Acquired	2026-05-18	Common Stock (132634)	Direct

Footnotes

F1: Pursuant to the policies of Pryor Cashman, the law firm of which Mr. Remmel is a partner, the options Mr. Remmel receives for his services as a director are assigned to the firm.

F2: The options shall vest on a quarterly basis over the next 12 months.